FDA WARNING_LETTER - Copper Touch, LLC - April 17, 2020
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
On April 21, 2020, the FDA and FTC issued a Warning Letter to the company operating coppertouch.com after reviewing their website on April 15 and 17, 2020. The letter addresses the sale of "Sani-Bar GK95" and "Sani-Disc GK95D" products, which are marketed with claims to mitigate, prevent, treat, diagnose, or cure COVID-19.
The FDA determined these products are unapproved new drugs, violating section 505(a) of the FD&C Act (21 U.S.C. § 355(a)), and are misbranded drugs under section 502 (21 U.S.C. § 352). The introduction of these products into interstate commerce is prohibited by sections 301(a) and (d) (21 U.S.C. § 331(a) and (d)). The letter highlights the public health emergency declared for COVID-19.
The company is required to immediately cease selling these unapproved and unauthorized products for COVID-19 related uses. Within 48 hours, the company must email COVID-19-Task-Force-CDER@fda.hhs.gov detailing corrective actions, including steps to prevent recurrence and supporting documentation. Failure to comply may result in legal action, including
ID · 4d41e25d-3794-4c7b-b43f-df01871026a9
Full citation text and observation details available on the Dashboard.